447 related articles for article (PubMed ID: 26874691)
1. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
3. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
4. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.
Ahrens R; Waddell A; Seidu L; Blanchard C; Carey R; Forbes E; Lampinen M; Wilson T; Cohen E; Stringer K; Ballard E; Munitz A; Xu H; Lee N; Lee JJ; Rothenberg ME; Denson L; Hogan SP
J Immunol; 2008 Nov; 181(10):7390-9. PubMed ID: 18981162
[TBL] [Abstract][Full Text] [Related]
5. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Ohkawara T; Nishihira J; Takeda H; Hige S; Kato M; Sugiyama T; Iwanaga T; Nakamura H; Mizue Y; Asaka M
Gastroenterology; 2002 Jul; 123(1):256-70. PubMed ID: 12105854
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.
Manousou P; Kolios G; Valatas V; Drygiannakis I; Bourikas L; Pyrovolaki K; Koutroubakis I; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2010 Nov; 162(2):337-47. PubMed ID: 21077277
[TBL] [Abstract][Full Text] [Related]
10. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
[TBL] [Abstract][Full Text] [Related]
11. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
13. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus carrying thymosin β
Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
[TBL] [Abstract][Full Text] [Related]
15. High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.
Coburn LA; Horst SN; Chaturvedi R; Brown CT; Allaman MM; Scull BP; Singh K; Piazuelo MB; Chitnavis MV; Hodges ME; Rosen MJ; Williams CS; Slaughter JC; Beaulieu DB; Schwartz DA; Wilson KT
PLoS One; 2013; 8(12):e82300. PubMed ID: 24367513
[TBL] [Abstract][Full Text] [Related]
16. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
17. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
20. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]